Icahn School of Medicine at Mount Sinai — New York, New York

Public research footprint of Icahn School of Medicine at Mount Sinai, compiled from the ClinicalTrials.gov public registry.

1,435

Registered studies

483

Active

291

Recruiting now

719

Completed

196

Stopped or withdrawn

Most-studied conditions

Lupus Nephritis · Early Parkinson Disease (Early PD) · Leukemia, Lymphocytic, Chronic, B-Cell · Idiopathic Parkinson Disease

Recently updated registry entries

NCT07015983 — A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in… (Active Not Recruiting)
NCT04924075 — Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… (Recruiting)
NCT06624670 — A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Icahn School of Medicine at Mount Sinai?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.